Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:31 PM
Ignite Modification Date:
2025-12-24 @ 6:31 PM
NCT ID:
NCT02809157
Eligibility Criteria:
Inclusion Criteria:
1. Aged 21-98.
2. Undergoing coronary angiography, who had received coronary CTA within 2 months before the scheduled coronary angiography.
Exclusion Criteria:
1. Individuals unable to provide informed consent.
2. Non-cardiac illness with life expectancy \<2 years.
3. Pregnant or breastfeeding state. Female patients who have a chance of becoming pregnant will receive pregnancy testing to exclude pregnant women from entering the study.
4. Allergy to iodinated contrast.
5. Significant arrhythmia; heart rate ≥ 100 beats/min; systolic blood pressure ≤90 mmHg.
6. Renal dysfunction (Glomerular filtration rate (GFR) \<30 mL/min/1.73m2).
7. Contraindication to beta blockers or nitroglycerin.
8. Canadian Cardiovascular Society class IV angina.
9. Significant valvular pathology
10. Previous coronary artery bypass surgery
11. Previous Percutaneous coronary intervention
12. Contraindication to adenosine administration (e.g. asthma, chronic obstructive pulmonary disease, heart rate \<50 beats/min)
13. Patients with an acute myocardial infarction or unstable arrhythmias
14. Patients with a left ventricular ejection fraction less than 30%
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
21 Years
Maximum Age:
98 Years
Study:
NCT02809157
Study Brief:
Protocol Section:
NCT02809157